top
Search terms
Results 1 - 10 of 41 - ordered by :
Pages: 1 2 3 4 5 ... 5
Epeuropace

6.1.4.1 Heart failure with reduced left ventricular ejection fraction and New York Heart Association class III/ambulatory class IV Table A. Cardiac resynchronization therapy in the primary prevention ...

Europace, ESC GUIDELINES, Authors/Task Force Members, Silvia G. Priori, Carina Blomström-Lundqvist, Andrea Mazzanti, Nico Blom, Martin Borggrefe, John Camm, Perry Mark Elliott, Donna Fitzsimons, ...

Date : 01/11/2015 Item size : 3637853 bytes
Epeuropace

Implantable cardioverter-defibrillatorElderlySurvivalSafetyClinical effectivenessCost-effectivenessRisk stratificationArrhythmiaSudden deathIntroduction Implantable cardioverter-defibrillators (ICDs) ...

Europace, Review, Sérgio Barra, Rui Providência, Luís Paiva, Patrick Heck, Sharad Agarwal

Date : 01/02/2015 Item size : 463275 bytes
Epeuropace

Abstract Aims Adaptive cardiac resynchronization therapy (aCRT) is a novel algorithm for CRT pacing that provides automatic ambulatory selection between synchronized left ventricular (LV) or ...

Europace, CLINICAL RESEARCH, Jagmeet P. Singh, William T. Abraham, Eugene S. Chung, Tyson Rogers, Alex Sambelashvili, James A. Coles, David O. Martin

Date : 01/11/2013 Item size : 269788 bytes
Epeuropace

Patients with AF are reported to have a five-fold increased risk of stroke; moreover, compared with the other identified risk factors for stroke (hypertension, heart failure, and coronary heart ...

Europace, Review, Jean-Pierre Bassand

Date : 01/03/2012 Item size : 404682 bytes
Epeuropace

Abstract Aims Reduction of unnecessary ventricular pacing (uVP) is an essential component in the treatment strategy in any pacing population in general. The aim of this study was to evaluate the ...

Europace, Pacing and resynchronization therapy, Hermine R. Poghosyan, Smbat V. Jamalyan

Date : 01/10/2012 Item size : 236215 bytes
Epeuropace

Abstract Multiple prospective randomized trials with implantable cardioverter defibrillators (ICDs) over the past decade have convincingly established the efficacy of ICD therapy in reducing ...

Europace, ICD, Seah Nisam, Günter Breithardt

Date : 01/06/2006 Item size : 211079 bytes
Epeuropace

Clinical trials of the implantable cardioverterdefibrillator (ICD) have demonstrated a survival benefit over medical therapy for the prevention of sudden cardiac death, but its benefit in patients ...

Europace, Sudden Death and ICDs, Eric S. Williams, Svati H. Shah, Jonathan P. Piccini, Albert Y. Sun, Jason I. Koontz, Sana M. Al-Khatib, Patrick M. Hranitzky

Date : 01/12/2011 Item size : 230939 bytes
Epeuropace

Introduction Heart failure is a common clinical syndrome affecting 2.5% adults in developed countries and the cost of heart failure exceeds $33 billion per year.1 It substantially impairs quality of ...

Europace, CLINICAL RESEARCH, Shaojie Chen, Yuehui Yin, Mitchell W. Krucoff

Date : 01/11/2012 Item size : 220613 bytes
Epeuropace

[...]we compared atrial antitachycardia pacing (ATP) therapy and combined atrial ATP and atrial pace prevention (ATP + Prevention) algorithms to conventional DDD/R pacing for prevention of AT/AF over ...

Europace, Anne M. Gillis, Margaret Morck, Derek V. Exner, Robert S. Sheldon, Henry J. Duff, Brent L. Mitchell, George D. Wyse

Date : 01/08/2009 Item size : 245281 bytes
Epeuropace

Abstract Aims Whether skeletal myoblast (SM) implants are proarrhythmic is still controversial due to conflicting pre-clinical and clinical data. Introduction Pilot clinical studies on the ...

Europace, BASIC SCIENCE, Javier Moreno, Jorge G. Quintanilla, Antonio López-Farré, Tamara Archondo, Raquel Cervigón, Paloma Aragoncillo, Elena Usandizaga, Jacobo Silva, Cruz ...

Date : 01/11/2010 Item size : 228607 bytes